Marketwatch Biocon Q2 results: Net profit drops 22% on higher R&D cost; revenue jumps 10% Admin October 23, 2020 Biocon reported a 10% rise in total revenue to Rs 1,760 crore driven by overall growth in generics, biosimilar and research services businesses. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email
